Gavekal KL Allocation Fund
 

GAVIX (I-share) 13.95
GAVAX (A-share) 13.82
Thu, Aug 27, 2015, 5:21PM EDT - U.S. Markets closed

PDF  Fact Sheet 

PDF  Presentation

 

Investment Objective: To seek long-term capital appreciation with an emphasis on capital preservation. 

Investment Strategy: The Fund employs an allocation strategy, moving between equities, fixed income and cash depending on market factors. Equity investments are selected from an index of companies the investment team identifies as Knowledge Leaders.

A Knowledge Leaders Strategy: Gavekal’s strategy seeks to transform the Knowledge Effect into portfolio alpha. The investment process aims to capture this market inefficiency using a proprietary methodology which capitalizes corporate knowledge investments, measures firm performance on a knowledge-adjusted basis, and selects investments in Knowledge Leader companies on the basis of knowledge intensity.

3 Ways to Use the Fund: May help investors improve
• Portfolio performance • Portfolio efficiency • Downside protection

Key Facts

Inception Date:
Morningstar Category:
Lipper Category:
I-share/A-share:
CUSIP:
Net Expense Ratio:
Distribution Frequency:
Benchmark: 

9/30/2010
Aggressive Allocation
Flexible Portfolio
GAVIX/GAVAX
461418659
1.28%/1.53%
Annually
MSCI ACWI

 

Performance
(as of 7/31/2015)

 

As of 6/30/2015, the 1-year and since inception annualized total returns for the Gavekal KL Allocation Fund Advisor Class were 5.68% and 9.47% and Institutional Class were 5.90% and 9.78%, respectively. The MSCI All Country World Index’s 1-year and since inception annualized total return as of 6/30/2015 were 0.71% and 9.46%. The total annual operating expenses of the Fund are 1.48% and 1.23% and net expenses are 1.53% and 1.28% for the Advisor and Institutional Classes, respectively. The inception date for the Gavekal KL Allocation Fund is 09/30/10.

The performance data quoted here represents past performance. Past performance is no guarantee of future results. Investment return and principal value will fluctuate, so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance information quoted. To obtain performance information current to the most recent month-end please call 888.998.9890 or visit our website at www.Gavekalfunds.com.

A redemption fee of 2.00% will be imposed on redemptions or exchanges of share you have owned for 90 days or less.

The Fund’s advisor has contractually agreed to waive its fees and/or pay for operating expenses of the Fund to ensure that total annual fund operating expenses do not exceed 1.50% and 1.25% of the average daily net assets for Advisor Class and Institutional Class shares of the Fund, respectively. This agreement is in effect until March 31, 2016. The Fund’s advisor is permitted to seek reimbursement from the Fund of fees waived for a period of three years from the date of the waiver or payment.

Effective March 31, 2015, the Advisor changed the Fund’s primary benchmark from the MSCI World Index to the MSCI All Country World Index in connection with a change in the Fund’s principal strategies. The Advisor believes the MSCI All Country World Index is a better measure of the Fund’s performance.

*Past performance is no guarantee of future results. The Lipper ratings are subject to change every month and are based on an equal-weighted average of percentile ranks for the Total Return metrics over three-, five-, and 10-year periods (if applicable). Lipper Leaders for Total Return reflects a fund’s historical total return performance relative to its peer group. The highest 20% of funds in each peer group are named Lipper Leaders, the next 20% receive a score of 4, the middle 20% are scored 3, the next 20% are scored 2, and the lowest 20% are scored 1. The Gavekal KL Allocation Fund (GAVIX) in Lipper’s Flexible Portfolio classification, received the following ratings for the three-year and overall time periods, respectively: 4 rating (among 388 Flexible Portfolio funds) and 5 rating (out of 390 Flexible Portfolio funds). Lipper ratings are not intended to predict future results and Lipper does not guarantee the accuracy of this information. More information is available at www.lipperleaders.com. Lipper Leader Copyright 2015, Reuters, All Rights Reserved.

Risk Metrics
(as of 7/31/2015 - Trailing 4 Years)

Risk Metrics
GAVIX
GAVAX
MSCI All Country World Index
Beta
0.41
0.41
1.00
Alpha
7.32
7.04
0.00
Standard Deviation
6.91
6.88
13.06
Tracking Error (%)
8.90
8.88
0.00
Sharpe Ratio
1.63
1.59
0.64
Treynor Ratio
27.65
26.92
8.41
Correlation (%)
77.00
77.00
100.00
Upside Capture
66.36
65.53
100.00
Downside Capture
27.22
27.95
100.00
Max Drawdown
-3.32
-3.34
-16.06
Active Share
91.61
91.61
0.00

Allocations
(as of 7/31/2015)

Asset Allocations

Asset
Percent
Equity
75.86
Fixed Income
12.00
Cash
10.96

Equity Allocations by Sector

Sector
Percent
Health Care
41.00
Information Technology
27.92
Consumer Staples
20.15
Consumer Discretionary
7.21
Materials
2.55
Industrials
1.17

Equity Allocations by Country

Country
Percent
United States
54.93
Japan
37.45
Switzerland
3.83
United Kingdom
2.56
France
1.23

Top 20 Equity Holdings
(as of 7/31/2015)

Top 20 Equity Holdings
 Percent
Citrix Systems Inc
2.24
Shiseido Co Ltd
1.94
Meiji Holdings Co Ltd
1.78
Eli Lilly & Co
1.70
CR Bard Inc
1.67
Nitori Holdings Co Ltd
1.65
Terumo Corp
1.62
Becton Dickinson & Co
1.58
Kao Corp
1.58
Laboratory Corp
1.57
Henry Schein Inc
1.54
Abbott Laboratories
1.52
Intuit
1.52
Fujifilm Holdings Corp
1.50
Astellas Pharma Inc
1.49
Quest Diagnostics Inc
1.49
Medtronic Plc
1.49
Mitsubishi Tanabe Pharma Corp
1.47
Santen Pharmaceutical Co Ltd
1.44
Takashimaya Co Ltd
1.44

PDF View Entire Portfolio Holdings

Investor Resources

XBRL – March 2015

For more information about XBRL (eXtensible Business Reporting Language) and a free XBRL reader, click here.

See Terms and Conditions

On March 31, 2015, the Fund’s name changed from Gavekal Knowledge Leaders Fund, to the Gavekal KL Allocation Fund. The investment objective and principal investment strategies have also changed. Further information regarding these matters is provided in the Fund’s revised Summary Prospectus, Prospectus and Statement of Additional Information dated March 31, 2015. 

Please consider the Fund’s investment objectives, risks, charges and expenses before investing. The prospectus or summary prospectus that contains this and other information about the Fund, is available by calling 888.998.9890 and should be read carefully.

The value of the securities held by the Fund will change due to general market and economic conditions and industry perceptions. Investments in non-US issuers may involve unique risks. Currency fluctuation, adverse political, economic or social developments could undermine the value of the Fund’s investments. The securities of mid-cap companies may be subject to more abrupt or erratic market movements and may have lower trading volumes. Many of the risks with respect to foreign investments are more pronounced for investments in issuers in developing or emerging market countries. An investment in a fund that is less diversified across countries or geographic regions is generally riskier than an investment in a more geographically diversified fund.

Portfolio composition will change due to ongoing management of the Fund. References to specific securities or sectors should be construed as recommendations by the Fund, its Advisor or Distributor.  The blended benchmark is comprised 60% of the MSCI All Country World Index and 40% of the Barclays US Treasury Bond Index.  Percentages are allocated to equity invested. 

The Gavekal KL Allocation Fund is distributed by IMST Distributors, LLC. 

Lipper Leaders fund ratings do not constitute and are not intended to constitute investment advice or an offer to sell or the solicitation of an offer to buy any security of any entity in any jurisdiction. As a result, you should not make an investment decision on the basis of this information. Rather, you should use the Lipper ratings for informational purposes only. Certain information provided by Lipper may relate to securities that may not be offered sold or delivered within the United States (or any State thereof) or to, or for the account or benefit of, United States persons.

Lipper is not responsible for the accuracy, reliability or completeness of the information that you obtain from Lipper. In addition, Lipper will not be liable for any loss or damage resulting from information obtained from Lipper or any of its affiliates. © Thomson Reuters 2015. All rights reserved.